2-PYRIDYL SUBSTITUTED IMIDAZOLES AS THERAPEUTIC ALK5 AND/OR ALK4 INHIBITORS

This invention relates to 2-pyridyl substituted imidazoles (I) which are inhibitors of the transforming growth factor-² (TGF-²) type I receptor (ALK5) and/or the activin type I receptor (ALK4), methods for their preparation, and their use in medicine, specifically in the treatment and prevention of...

Full description

Saved in:
Bibliographic Details
Main Authors SHEEN, YHUN, YHONG, PARK, CHUL-YONG, KIM, DAE, KEE, SREENU, DOMALAPALLY, SUBRAHMANYAM, VURA, BALA, RAO, KOTA, SUDHAKAR, JIN, CHENG, HUA, KRISHNAIAH, MADDEBOINA
Format Patent
LanguageEnglish
Serbian
Published 30.03.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This invention relates to 2-pyridyl substituted imidazoles (I) which are inhibitors of the transforming growth factor-² (TGF-²) type I receptor (ALK5) and/or the activin type I receptor (ALK4), methods for their preparation, and their use in medicine, specifically in the treatment and prevention of a disease state mediated by these receptors.
AbstractList This invention relates to 2-pyridyl substituted imidazoles (I) which are inhibitors of the transforming growth factor-² (TGF-²) type I receptor (ALK5) and/or the activin type I receptor (ALK4), methods for their preparation, and their use in medicine, specifically in the treatment and prevention of a disease state mediated by these receptors.
Author JIN, CHENG, HUA
KIM, DAE, KEE
SUBRAHMANYAM, VURA, BALA
SREENU, DOMALAPALLY
RAO, KOTA, SUDHAKAR
PARK, CHUL-YONG
SHEEN, YHUN, YHONG
KRISHNAIAH, MADDEBOINA
Author_xml – fullname: SHEEN, YHUN, YHONG
– fullname: PARK, CHUL-YONG
– fullname: KIM, DAE, KEE
– fullname: SREENU, DOMALAPALLY
– fullname: SUBRAHMANYAM, VURA, BALA
– fullname: RAO, KOTA, SUDHAKAR
– fullname: JIN, CHENG, HUA
– fullname: KRISHNAIAH, MADDEBOINA
BookMark eNrjYmDJy89L5WTwNtINiAzydIn0UQgOdQoO8QwJDXF1UfD09XRxjPL3cQ1WcAxWCPFwDXIMcA0N8XRWcPTxNlVw9HPR9w8CsU0UPP08PJ08Q_yDgnkYWNMSc4pTeaE0N4Ocm2uIs4duakF-fGpxQWJyal5qSXxQsKmZuaGBk6ExQQUAppUuQg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 2-PIRIDIL SUPSTITUISANI IMIDAZOLI KAO TERAPEUTSKI INHIBITORI ALK5 I/ILI ALK4
ExternalDocumentID RS56710B1
GroupedDBID EVB
ID FETCH-epo_espacenet_RS56710B13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:11:25 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Serbian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_RS56710B13
Notes Application Number: RS2017P001245
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180330&DB=EPODOC&CC=RS&NR=56710B1
ParticipantIDs epo_espacenet_RS56710B1
PublicationCentury 2000
PublicationDate 20180330
PublicationDateYYYYMMDD 2018-03-30
PublicationDate_xml – month: 03
  year: 2018
  text: 20180330
  day: 30
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION
RelatedCompanies_xml – name: EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION
Score 3.1336877
Snippet This invention relates to 2-pyridyl substituted imidazoles (I) which are inhibitors of the transforming growth factor-² (TGF-²) type I receptor (ALK5) and/or...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 2-PYRIDYL SUBSTITUTED IMIDAZOLES AS THERAPEUTIC ALK5 AND/OR ALK4 INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180330&DB=EPODOC&locale=&CC=RS&NR=56710B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb8IwDI4Qm7bdNvZgL5TD1FtFWR_QQzW1TVE7oK2SdoJdEJRk2gUQdNrfn4nKtgs3K5Esx5IfXxLbCD3NOrbgkEaoJuQeqsHFQrW5LlRdKzqmsMXCkpPnRrEV5sbr2BzX0Me-Fkb2Cf2WzRHBogqw91L66_XfJRaRfyu37fknLK1e-plDlAodd3oa4HOFeE6QJiTxFd93KFNi6pgWhFIPYNIR5NBdidjevF1Jyvp_POmfo-MUWC3LC1Tbbhro1N-PXWugk1H12g1kZXjbSzR4VtMJjchkiFnusSzKcnA5GDwPcd-TYcCwy3AWBtRNgzyLfOwOByZ2Y9JO6I42cBSHkRdlCWVXqNUPMj9UQarp7_mnlFXS69eovlwteRNhk2td0dVmfA4JjW707GJWAJITAKesBTi_W3RzgMndwZ17dLZToay40x5Qvdx88UcIueW8JdX1A6ybf_k
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8JAEJ4QNOJN8YEv3IPpraHYB_TQmL5IK6VtulsDXgiU1ngBAjX-fYdNUS_cJrvJZHaSeXy7OzMAT7OuXuSYRogq5h6ikhcLUc_lQpSlrKsWerHQ-OS5Uah5qfI6Vsc1-NjXwvA-od-8OSJaVIb2XnJ_vf67xHL438ptZ_6JS6uXATMcoULH3b6E-FxwLMONIyeyBds2EiqEiaFqGEothElHmF_3OU56s3YlKev_8WRwBscxslqW51DbbprQsPdj15pwMqpeu5GsDG97AcNnMZ4kvjMJCE0tynyWossh6Hkc8z0KXEpMSpjnJmbspsy3iRkMVWKGTidKdrRC_NDzLZ9FCb2E9sBltieiVNPf808TWkkvX0F9uVrmLSBqLvWKnjTL55jQyEpfz2YZIrkC4ZS2QOd3A9cHmNwe3HmEhsdGwTTww-EdnO7UyavvpHuol5uv_AHDbzlvc9X9ANUFguk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=2-PYRIDYL+SUBSTITUTED+IMIDAZOLES+AS+THERAPEUTIC+ALK5+AND%2FOR+ALK4+INHIBITORS&rft.inventor=SHEEN%2C+YHUN%2C+YHONG&rft.inventor=PARK%2C+CHUL-YONG&rft.inventor=KIM%2C+DAE%2C+KEE&rft.inventor=SREENU%2C+DOMALAPALLY&rft.inventor=SUBRAHMANYAM%2C+VURA%2C+BALA&rft.inventor=RAO%2C+KOTA%2C+SUDHAKAR&rft.inventor=JIN%2C+CHENG%2C+HUA&rft.inventor=KRISHNAIAH%2C+MADDEBOINA&rft.date=2018-03-30&rft.externalDBID=B1&rft.externalDocID=RS56710B1